Germany · Delayed Price · Currency is EUR Healthpeak Properties Statistics
Total Valuation
FRA:HC5 has a market cap or net worth of EUR 10.87 billion. The enterprise value is 19.49 billion.
| Market Cap | 10.87B |
| Enterprise Value | 19.49B |
Important Dates
The next estimated earnings date is Friday, February 6, 2026.
| Earnings Date | Feb 6, 2026 |
| Ex-Dividend Date | Nov 14, 2025 |
Share Statistics
| Current Share Class | 694.95M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.31% |
| Shares Change (QoQ) | -0.04% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 95.99% |
| Float | 692.08M |
Valuation Ratios
| Price/FFO Ratio | 10.30 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | 68.38 |
| PS Ratio | 4.55 |
| PB Ratio | 1.54 |
| P/TBV Ratio | 1.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 10.28 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -587.20 |
| EV / Sales | 8.09 |
| EV / EBITDA | 16.62 |
| EV / EBIT | 69.56 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.65, with a Debt / Equity ratio of 1.14.
| Current Ratio | 3.65 |
| Quick Ratio | 1.47 |
| Debt / Equity | 1.14 |
| Debt / EBITDA | 6.13 |
| Debt / FCF | n/a |
| Interest Coverage | 1.70 |
Financial Efficiency
Return on equity (ROE) is -0.12% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | -0.12% |
| Return on Assets (ROA) | 1.59% |
| Return on Invested Capital (ROIC) | 1.75% |
| Return on Capital Employed (ROCE) | 2.62% |
| Revenue Per Employee | 6.17M |
| Profits Per Employee | -85,750 |
| Employee Count | 387 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -9.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -24.52% |
| 50-Day Moving Average | 15.69 |
| 200-Day Moving Average | 15.97 |
| Relative Strength Index (RSI) | 55.56 |
| Average Volume (20 Days) | 40 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, FRA:HC5 had revenue of EUR 2.39 billion and -33.19 million in losses. Loss per share was -0.05.
| Revenue | 2.39B |
| Gross Profit | 1.43B |
| Operating Income | 428.24M |
| Pretax Income | -17.77M |
| Net Income | -33.19M |
| EBITDA | 1.29B |
| EBIT | 428.24M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 84.19 million in cash and 8.05 billion in debt, giving a net cash position of -7.96 billion.
| Cash & Cash Equivalents | 84.19M |
| Total Debt | 8.05B |
| Net Cash | -7.96B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 7.04B |
| Book Value Per Share | 9.32 |
| Working Capital | 840.26M |
Cash Flow
| Operating Cash Flow | 1.06B |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 59.74%, with operating and profit margins of 17.94% and -1.36%.
| Gross Margin | 59.74% |
| Operating Margin | 17.94% |
| Pretax Margin | -0.74% |
| Profit Margin | -1.36% |
| EBITDA Margin | 54.01% |
| EBIT Margin | 17.94% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 6.34%.
| Dividend Per Share | 1.00 |
| Dividend Yield | 6.34% |
| Dividend Growth (YoY) | -10.29% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -9.31% |
| Shareholder Yield | -2.97% |
| Earnings Yield | -0.31% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |